ANBISON LAB
GenericsANBISON LAB is a generic drug manufacturer focused on Neurology.
ANBISON LAB's Key Drugs
ANBISON LAB's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ANBISON LAB's Recent FDA Approvals
New NDA/BLA approvals for ANBISON LAB over the last two years — novel drugs only, excluding generics and label supplements.
ANBISON LAB's Therapeutic Areas
ANBISON LAB's approved drugs and pipeline span 1 therapeutic area, led by Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ANBISON LAB's Top Competitors
ANBISON LAB's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ANBISON LAB Pipeline Snapshot
Active clinical trials for ANBISON LAB across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2015-11-05
- Latest
- 2024-10-07
- Applications
- 4